Literature DB >> 9470054

Efficacy of parenteral administration of three antimicrobial agents in treatment of clinical mastitis in lactating cows: 487 cases (1989-1995).

S H Pyörälä1, E O Pyörälä.   

Abstract

OBJECTIVE: To evaluate the efficacy of parenteral administration of procaine penicillin G, spiramycin, or enrofloxacin in the treatment of clinical mastitis in lactating cows.
DESIGN: Noncontrolled, clinical retrospective study. ANIMALS: 487 cows with mastitis involving 543 quarters. PROCEDURE: Clinical signs, histories, and results of bacteriologic examination, somatic cell count, and N-acetyl-beta-D-glucosaminidase activity of milk samples taken before and 3 to 4 weeks after treatment were retrieved from hospital records. Cows treated parenterally with procaine penicillin G, spiramycin, or enrofloxacin for 3 to 5 days were included. Supportive treatment alone was given to 35 cows infected with Escherichia coli. Factors possibly affecting outcome were analyzed, using ANOVA, correlation analyses, and the Mann-Whitney test. chi 2 Test was used to compare bacteriologic cure rates.
RESULTS: Bacteriologic cure rates for mastitis caused by Staphylococcus aureus, coagulase-negative staphylococci, and streptococci were 34, 76, and 65%, respectively. Cure rates in cows in their first lactation and infected with S aureus and coagulase-negative staphylococci were significantly higher than those for older cows. In cows with mastitis caused by E coli, the cure rate was 74% for those treated with penicillin G and 71% for those not treated with antimicrobials. High N-acetyl-beta-D-glucosaminidase activity in milk samples obtained at initial examination indicated a poor outcome in S aureus and streptococcal mastitis. Cows infected in the early lactation period had more severe inflammatory responses and clinical signs if infected with coagulase-negative staphylococci and coliforms. CLINICAL IMPLICATIONS: 3 to 5 days of treatment with parenterally administered penicillin G for clinical mastitis caused by penicillin-susceptible S aureus strains is efficacious in young cows. Parenteral administration of spiramycin or enrofloxacin does not give satisfactory results in mastitis caused by penicillin-resistant S aureus. Use of antimicrobials in the treatment of mastitis caused by coliform bacteria is questionable.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9470054

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  9 in total

Review 1.  Mastitis therapy and antimicrobial susceptibility: a multispecies review with a focus on antibiotic treatment of mastitis in dairy cattle.

Authors:  John Barlow
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-10-09       Impact factor: 2.673

2.  Acute phase response in dairy cows with experimentally induced Escherichia coli mastitis.

Authors:  J Hirvonen; K Eklund; A M Teppo; G Huszenicza; M Kulcsar; H Saloniemi; S Pyörälä
Journal:  Acta Vet Scand       Date:  1999       Impact factor: 1.695

3.  Treatment of mastitis during lactation.

Authors:  S Pyörälä
Journal:  Ir Vet J       Date:  2009-04-01       Impact factor: 2.146

4.  Associations between bacterial genotype and outcome of bovine clinical Staphylococcus aureus mastitis.

Authors:  Asa Lundberg; Anna Aspán; Ann Nyman; Helle Ericsson Unnerstad; Karin Persson Waller
Journal:  Acta Vet Scand       Date:  2014-01-08       Impact factor: 1.695

5.  Bactericidal and Anti-biofilm Effects of Polyhexamethylene Biguanide in Models of Intracellular and Biofilm of Staphylococcus aureus Isolated from Bovine Mastitis.

Authors:  Nor F Kamaruzzaman; Stacy Q Y Chong; Kamina M Edmondson-Brown; Winnie Ntow-Boahene; Marjorie Bardiau; Liam Good
Journal:  Front Microbiol       Date:  2017-08-11       Impact factor: 5.640

6.  Risk Factors for the Occurrence of Methicillin-Resistant Staphylococcus aureus in Dairy Herds: An Update.

Authors:  Arne Schnitt; Bernd-Alois Tenhagen
Journal:  Foodborne Pathog Dis       Date:  2019-08-28       Impact factor: 3.171

7.  Efficacy of targeted 5-day combined parenteral and intramammary treatment of clinical mastitis caused by penicillin-susceptible or penicillin-resistant Staphylococcus aureus.

Authors:  S Taponen; A Jantunen; E Pyörälä; S Pyörälä
Journal:  Acta Vet Scand       Date:  2003       Impact factor: 1.695

8.  Association between virulence factors and clinical course of Escherichia coli mastitis.

Authors:  T Lehtolainen; T Pohjanvirta; S Pyörälä; S Pelkonen
Journal:  Acta Vet Scand       Date:  2003       Impact factor: 1.695

9.  Antimicrobial Selection for the Treatment of Clinical Mastitis and the Efficacy of Penicillin Treatment Protocols in Large Estonian Dairy Herds.

Authors:  Anri Timonen; Marju Sammul; Suvi Taponen; Tanel Kaart; Kerli Mõtus; Piret Kalmus
Journal:  Antibiotics (Basel)       Date:  2021-12-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.